NASDAQ · ATHE
Alterity Therapeutics Limited
Healthcare · Biotechnology
$2.44
Down-$0.03 (-1.21%)
Updated Nov 5, 2026, 2:57 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 31.19M
- P/E ratio
- -4.93
- Dividend yield
- 0.00%
- 52-week range
- $2.01 – $5.89
- Volume
- 131.52K
- Avg. volume
- 14.18K
Price performance · ATHE
ATHE price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
ATHE closed at $2.44 after 21 trading sessions, down 26.51% for the selected period.
- Last close
- $2.44
- Period change
- -26.51%
- Period low
- $2.08
- Period high
- $3.32
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $2.47 | $2.65 | $2.37 | $2.44 | 131.52K |
| Nov 3, 2026 | $2.10 | $3.2894 | $2.10 | $2.47 | 4.04M |
| Nov 2, 2026 | $2.17 | $2.235 | $2.09 | $2.09 | 6.06K |
| Oct 30, 2026 | $2.23 | $2.24 | $2.11 | $2.16 | 9.06K |
| Oct 29, 2026 | $2.25 | $2.255 | $2.16 | $2.2335 | 3.79K |
| Oct 28, 2026 | $2.20 | $2.29 | $2.15 | $2.17 | 23.31K |
| Oct 27, 2026 | $2.14 | $2.24 | $2.02 | $2.14 | 3.53K |
| Oct 26, 2026 | $2.08 | $2.3562 | $2.01 | $2.08 | 7.91K |
| Oct 23, 2026 | $2.12 | $2.43 | $2.04 | $2.09 | 26.79K |
| Oct 22, 2026 | $2.26 | $2.2887 | $2.089 | $2.15 | 53.31K |
| Oct 21, 2026 | $2.44 | $2.615 | $2.30 | $2.39 | 56.52K |
| Oct 20, 2026 | $2.41 | $2.51 | $2.37 | $2.37 | 17.73K |
| Oct 19, 2026 | $2.65 | $2.655 | $2.425 | $2.43 | 21.93K |
| Oct 16, 2026 | $2.56 | $2.955 | $2.35 | $2.62 | 55.91K |
| Oct 15, 2026 | $2.67 | $2.84 | $2.62 | $2.72 | 37.48K |
| Oct 14, 2026 | $2.88 | $3.40 | $2.78 | $2.81 | 53.25K |
| Oct 13, 2026 | $2.94 | $2.945 | $2.80 | $2.85 | 18.96K |
| Oct 12, 2026 | $3.07 | $3.09 | $2.82 | $2.93 | 31.65K |
| Oct 9, 2026 | $3.07 | $3.25 | $3.07 | $3.115 | 22.66K |
| Oct 8, 2026 | $3.21 | $3.3399 | $3.04 | $3.07 | 34.37K |
| Oct 7, 2026 | $3.41 | $3.51 | $3.29 | $3.32 | 19.34K |
Latest ATHE news
The latest Smart Investors Daily articles mentioning ATHE.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

